Epidermal Growth Factor Receptor Inhibitors in the Treatment of Nonmelanoma Skin Cancers

BACKGROUND
A better understanding of the molecular pathways that characterize cell growth, apoptosis, angiogenesis, and invasion has provided novel targets in cancer therapy. Epidermal growth factor receptor (EGFR)-mediated signal transduction has been one of the most studied pathways in carcinogenesis. The phosphorylation of EGFR activates multiple biological processes, including apoptosis, differentiation, cellular proliferation, motility, invasion, adhesion, DNA repair, and survival. EGFR is a transmembrane tyrosine kinase receptor involved in the proliferation and survival of cancer cells. EGFR is the first molecular target against which monoclonal antibodies have been developed for ...

Epidermal Growth Factor Receptor Inhibitors in the Treatment of Nonmelanoma Skin Cancers is a post from: Skincare

Epidermal Growth Factor Receptor Inhibitors in the Treatment of Nonmelanoma Skin Cancers via BuzzBlazer.com